Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:33 PM
Ignite Modification Date:
2025-12-24 @ 2:33 PM
NCT ID:
NCT02120859
Eligibility Criteria:
Inclusion Criteria:
* Indication for elective PCI according to the guidelines of European Society of Cardiology, American Heart Association and American College of Cardiology
* Age \> 18 years, written consent
* Native de novo coronary lesion suitable for angioplasty and OCT imaging
Exclusion Criteria:
* Pregnancy and breast feeding mother
* Co-morbidity with an estimated life expectancy of \< 50 % at 1 year
* Scheduled major surgery in the next 6 months
* Not able to give informed written consent or non-compliance
* Participation in other PCI trial
* Acute coronary syndromes and cardiogenic shock
* Known allergy to aspirin, thienopyridines or against taxol derivates
* Culprit lesion within the proximal 10 mm of the right or left coronary artery
* Saphenous vein grafts
* Estimated lesion length \> 30 mm
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02120859
Study Brief:
Protocol Section:
NCT02120859